A high-fat diet forces liver cells to adapt for survival rather than function, creating metabolic stress that affects ...

Influenza and respiratory infections are still considered to pose certain threats throughout the year, with changes in season ...

Pasta varies in difficulty, with some dishes perfectly accessible for home cooks, and others best left to the pros. We asked ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Officials have detected highly pathogenic avian influenza (HPAI) H5N1 in a dairy cattle herd in Wisconsin, according to the US Department of Agriculture’s (USDA’s) Animal and Plant Health Inspection ...

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...

Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...

Bitlock Wallet, a non-custodial multi-chain wallet originally launched as a native Telegram mini-app, announced today that its iOS and Android applications have entered the final stage of internal ...

Through a recent notice, the Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) has ...

At the recent ELRIG Drug Discovery conference, Technology Networks<i/> spoke with Dr. Kundan Sharma to learn more about how cell-free expression platforms are transforming membrane protein research.

Dark spots are one of the most frustrating skin concerns because they tend to linger long after the original trigger is gone. Whether they show up after acne, pregnancy, sun exposure, or inflammation, ...

Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...